EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Multifaceted Immunomodulatory Nanocomplexes Target Neutrophilic‐ROS Inflammation in Acute Lung Injury

Fan Su, Chong Zhang, Qianyun Zhang, Yi Shen, Saiqi Li, Jianlin Shi, Ya-Xuan Zhu, Han Lin iD, Bin He

Advanced Science · 2025-02 · 12 (8)

DOI: 10.1002/advs.202411823 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 31.12.2024. Verfasst von Fan Su und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Medicine and Emergency, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, 200030, P. R. China. Hauptthemen laut MEDLINE: Acute Lung Injury, Reactive Oxygen Species, Neutrophils, Immunomodulating Agents. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China, Program of Shanghai Academic/Technology Research Leader.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The sepsis‐induced acute lung injury (ALI) still represents one of the leading causes of death in critically ill patients, underscoring the need for novel therapies. Excessive activation of immune cells and damage of reactive oxygen species (ROS) are the main factors that exacerbate lung injury. Here, the multifaceted immunomodulatory nanocomplexes targeting the proinflammatory neutrophilic activation and ROS damage are established. The S100A8/9 inhibitor, ABR2575, is loaded in the nanocomplexes, which effectively blocks the neutrophils‐S100A8/A9‐ toll‐like receptors (TLRS)‐Inflammasome signaling in ALI. Synergically, the SiH nanosheets are encapsulated together with ABR2575 into the core of poly(lactic‐ co ‐glycolic acid) (PLGA) nanosponges, to achieve sustainable hydrogen release for the alleviation of ROS‐induced lung tissue injury, and also promote the M2 polarization of macrophages. This novel combination strategy is proven to significantly suppress the infiltration of neutrophils and pro‐inflammatory macrophages into the lungs, decrease the activation of neutrophils and pro‐inflammatory monocytes in the blood, facilitate the anti‐inflammatory polarization of macrophages and monocytes, and reduce the expression of pro‐inflammatory cytokines in both the lung and blood circulation, all of which alleviate the lung injuries in preclinical murine ALI models. The current investigations offer a novel nanomedicine for the treatment of ALI with great potential in clinical invention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Lung InjuryReactive Oxygen SpeciesNeutrophilsImmunomodulating AgentsNanoparticle Drug Delivery SystemNeutrophil ActivationHumansCalgranulin ANanostructuresModels, AnimalAnimalsMiceSilicatesFree Radical ScavengersMice, Inbred C57BLMaleCell Line

Stichwörter der Autor:innen

acute lung injuryhydrogen therapyneutrophilsreactive oxygen species

Substanzen

Reactive Oxygen SpeciesImmunomodulating AgentsS100A8 protein, humanCalgranulin ANanoparticle Drug Delivery Systemsilica hydrideSilicatesFree Radical Scavengers

Autor:innen und Institutionen

  • Department of Critical Care Medicine and Emergency, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, 200030, P. R. China.
  • Shanghai Tenth People's Hospital, Shanghai Frontiers Science Center of Nanocatalytic Medicine, School of Medicine, Tongji University, Shanghai, 200072, P. R. China.
  • State Key Laboratory of High Performance Ceramics and Superfine Microstructure, Shanghai Institute of Ceramics Chinese Academy of Sciences; Research Unit of Nanocatalytic Medicine in Specific Therapy for Serious Disease…

ORCID-Profile: Han Lin

Förderung

  • Fundamental Research Funds for the Central Universities
  • National Natural Science Foundation of China
  • Program of Shanghai Academic/Technology Research Leader
  • Shanghai Municipal Health Commission Talent Program
  • Chinese Academy of Sciences
  • Key Discipline of Shanghai Municipal Health System
  • Clinical management optimization project of Shanghai Hospital Development
  • Program of Shanghai Academic Research Leader

Zitieren

APA

Su, F., Zhang, C., Zhang, Q., Shen, Y., Li, S., Shi, J., Zhu, Y. X., Lin, H., & He, B. (2025). Multifaceted Immunomodulatory Nanocomplexes Target Neutrophilic‐ROS Inflammation in Acute Lung Injury. Advanced Science, 12(8). https://doi.org/10.1002/advs.202411823

Vancouver

Su F, Zhang C, Zhang Q, Shen Y, Li S, Shi J, et al. Multifaceted Immunomodulatory Nanocomplexes Target Neutrophilic‐ROS Inflammation in Acute Lung Injury. Advanced Science. 2025;12(8). doi:10.1002/advs.202411823

BibTeX
@article{Su2025,
  author = {Su, Fan and Zhang, Chong and Zhang, Qianyun and Shen, Yi and Li, Saiqi and Shi, Jianlin and Zhu, Ya-Xuan and Lin, Han and He, Bin},
  title = {Multifaceted Immunomodulatory Nanocomplexes Target Neutrophilic‐ROS Inflammation in Acute Lung Injury},
  journal = {Advanced Science},
  year = {2025},
  volume = {12},
  number = {8},
  doi = {10.1002/advs.202411823}
}
Kostenlos starten →